stella
beta
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis — Stella
Recruiting
Back to Decompensated Hepatitis B Cirrhosis trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Zhongnan Hospital of Wuhan University, Wuhan
View full record on ClinicalTrials.gov